CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
53.14
04-October-24 15:59:59
15 minutes delayed
Stocks
+0.37
+0.70%
Today's range
52.73 - 53.59
ISIN
N/A
Source
NASDAQ
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Apr 2022 17:15:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
30 Mar 2022 16:02:00 By Nasdaq GlobeNewswire
-
30 Mar 2022 16:01:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer
21 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Mar 2022 17:20:34 By Nasdaq GlobeNewswire
-
01 Mar 2022 08:00:18 By Nasdaq GlobeNewswire
-
28 Feb 2022 06:00:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference
09 Feb 2022 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Feb 2022 16:42:26 By Nasdaq GlobeNewswire
-
12 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
05 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
18 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
08 Nov 2021 08:00:03 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
05 Nov 2021 08:00:00 By Nasdaq GlobeNewswire
-
25 Oct 2021 16:01:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
21 Oct 2021 08:22:33 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
20 Oct 2021 16:01:37 By Nasdaq GlobeNewswire
-
18 Oct 2021 16:00:00 By Nasdaq GlobeNewswire
-
27 Sep 2021 07:30:00 By Nasdaq GlobeNewswire